Telemedicine
Search documents
How is Teladoc Health Placed in the Growing Telemedicine Market?
ZACKS· 2025-11-10 19:16
Core Insights - Teladoc Health (TDOC) is positioned to benefit from the growing telemedicine market, driven by regulatory support and increasing demand for remote healthcare services [2][10] - The U.S. telehealth market is projected to grow from $42.61 billion in 2024 to $358.96 billion by 2034, providing significant opportunities for Teladoc [4] - Teladoc's partnership with Microsoft aims to enhance its Solo platform with AI, improving clinical documentation and care quality [3][10] Company Positioning - Teladoc continues to invest heavily in client acquisition, provider network development, and technology innovation, which strengthens its competitive position in virtual care [5] - The company aims to be the primary "front door" to the healthcare system for millions of members globally [5] Market Dynamics - HCA Healthcare and CVS Health are also well-positioned to capitalize on telemedicine growth, with HCA integrating virtual care across its network and CVS leveraging its retail and pharmacy services [6][7] - Both competitors are investing in digital health infrastructure and remote monitoring to seize opportunities in the evolving healthcare landscape [8] Financial Performance - Teladoc's shares have decreased by 17.2% year to date, contrasting with a 3.1% increase in the industry [9] - The company is trading at a forward 12-month price-to-sales multiple of 0.53, higher than the industry average of 0.45 [11] Estimates and Projections - The Zacks Consensus Estimate for TDOC's fourth-quarter 2025 loss has narrowed by 1 cent, while the first-quarter 2026 loss has improved by 2 cents over the past 30 days [12] - The consensus estimates for 2025 revenues indicate a year-over-year decline, while those for 2026 suggest a year-over-year increase [12]
The S&P 500 Might Be Overheated, but Bank of America Sees Value in These 2 Stocks
Yahoo Finance· 2025-11-01 11:12
The increase in demand for medical services over the past decade or more has forced providers to look for alternative ways to keep abreast of new developments, meet with patients, confer with specialists – and has expanded the field of telemedicine. The Doximity app, which allows providers to speak directly with patients via video link, streamlines the process. Providers can set online call appointments, tend to other work, and receive alerts as callers – patients or colleagues – enter the conversation.Doxi ...
LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women’s Health Program
Globenewswire· 2025-10-22 12:00
Renowned Menopause and Hormone Specialist to Help Guide and Represent LifeMD’s Comprehensive and Personalized Care Offering for WomenNEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Tara Scott, MD, widely known as “The Hormone Guru,” as ambassador and clinical advisor for its comprehensive women’s health program. A respected physician, educator, and advocate, Dr. Scott will help champion LifeMD’s ...
Orbis International's Flying Eye Hospital Returns to Ghana to Train Local Eye Care Teams
Prnewswire· 2025-10-13 11:57
Core Insights - Orbis International is conducting a three-week training project in Ghana aboard the Orbis Flying Eye Hospital, aimed at enhancing local eye care capabilities and raising awareness about available resources [1][2][4] Group 1: Project Overview - This is the fourth visit of the Orbis Flying Eye Hospital to Ghana, with previous visits occurring between 1990 and 2019, contributing to the strengthening of the country's eye care system [2] - The training will focus on various eye conditions, including cataract, glaucoma, strabismus, and medical retina, with hands-on surgical training for eye care professionals [2][3] - The project involves collaboration with local institutions such as Korle Bu Teaching Hospital, Komfo Anokye Teaching Hospital, and the Ghana Ophthalmic Nursing School [1][2] Group 2: Support and Partnerships - The project is supported by the Alcon Foundation, FedEx, and OMEGA, with Alcon providing monetary donations and advanced ophthalmic equipment [5][6] - FedEx has donated the MD-10 aircraft for the Flying Eye Hospital and offers ongoing financial and operational support [6][7] - OMEGA has been a supporter of Orbis since 2011, contributing to various training projects and raising awareness of Orbis's mission [7][8] Group 3: Long-term Commitment and Impact - Orbis has been active in Ghana since 2014, focusing on pediatric ophthalmology and expanding eye care services across the country [9][10] - The organization has established 25 primary eye care units across 19 districts and improved facilities at national eye hospitals [10][11] - A permanent office in Accra has been opened to signify Orbis's long-term commitment to enhancing eye care in Ghana [11][12]
Should You Buy POM Stock After the PomDoctor IPO?
Yahoo Finance· 2025-10-10 18:57
Old timers will likely recall an episode of the hit sitcom Seinfeld in which George’s dad believed he was getting treatment from a Chinese herbal medicine practitioner. Although the legitimacy of the so-called Chinese herbal medicine practice of Donna Chang(stein) was questionable, the recently listed shares of this online Chinese medical platform started trading above their IPO price, reflecting demand and positive reception. About PomDoctor Founded in 2010 and headquartered in the Guangzhou province of ...
LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Globenewswire· 2025-09-25 20:06
Company Overview - LifeMD, Inc. is a leading provider of virtual primary care services, offering telemedicine, laboratory and pharmacy access, and specialized treatment for over 200 conditions [2] - The company utilizes a vertically integrated digital care platform, a 50-state affiliated medical group, a state-of-the-art compounding pharmacy, and a U.S.-based patient care center to enhance access to high-quality and affordable care [2] Recent Developments - LifeMD announced its participation in the ROTH 4 Annual Healthcare Opportunities Conference scheduled for October 9, 2025, in New York City [1] - Management will engage in one-on-one meetings with investors throughout the conference [1] - Investors interested in attending can register by contacting their ROTH Capital Partners representative [1]
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
ZACKS· 2025-09-24 18:16
Core Insights - The Zacks Medical - Outpatient and Home Healthcare industry is experiencing a significant shift towards digital healthcare, driven by rising demand for telemedicine and AI-powered services, particularly due to an aging global population and increasing healthcare costs [1][4][10] Industry Overview - The industry includes companies providing outpatient care using advanced medical technologies for diagnosis, treatment, and rehabilitation, with a focus on innovation and value-based care models [3] - The global home healthcare market was valued at $416.4 billion in 2024 and is projected to reach $747.70 billion by 2030, growing at a CAGR of approximately 10.2% [1] Major Trends - Aging Population: The growing elderly population is a primary driver for home healthcare services, as older individuals prefer receiving care in familiar home settings [4] - Cost Effectiveness: Outpatient clinics offer cost-effective care, reducing the financial burden on patients and healthcare systems [5] - AI's Role: AI enhances patient care through remote monitoring and data analysis, facilitating timely interventions and improving care management [7] - Technological Advancements: Virtual assistants and chatbots are increasingly used to assist patients in managing their care and appointments [8] Staffing Challenges - The U.S. healthcare industry faces severe staffing shortages, particularly among home health aides, exacerbated by high burnout rates and international migration of health workers [11] Market Performance - The industry has underperformed compared to the S&P 500, losing 0.5% over the past year, while the S&P 500 rose by 18.2% [14] - The industry's current valuation is at a forward P/E of 19.6X, compared to the S&P 500's 23.4X [18] Company Highlights - **Quest Diagnostics**: Anticipates 2025 revenue growth of 9.9% and earnings growth of 9.1%, with a current ROE of 15.2% [21][22][25] - **DaVita**: Expected revenue growth of 5% and earnings growth of 12.9% for 2025, with an impressive ROE of 369.4% [26][27][30] - **Addus HomeCare**: Forecasts a 21.5% increase in revenues and a 16.5% rise in earnings for 2025, with a ROE of 9.4% [31][32][34] - **The Pennant Group**: Projects a 26.5% growth in revenues and a 21.3% increase in earnings for 2025, with a ROE of 9.9% [35][36][37]
From Mobile Clinics to Surgical Robots: How Smart Tech Optimizes Eye Care?
2 1 Shi Ji Jing Ji Bao Dao· 2025-09-10 12:27
Group 1 - The WHO report indicates that at least 2.2 billion people globally suffer from vision impairment, with at least 1 billion cases being preventable or unaddressed [1] - There are significant challenges in eye care worldwide, despite advancements in technology [1] - Technological innovations such as artificial intelligence, big data, and telemedicine are improving healthcare resource allocation and enhancing diagnostic and treatment efficiency and accessibility [1] Group 2 - The Zhongshan Ophthalmic Center of Sun Yat-sen University in Guangdong exemplifies innovative solutions in the field of ophthalmology, showcasing "Chinese wisdom" [2]
X @Bloomberg
Bloomberg· 2025-08-11 15:25
Telemedicine has become a crucial access point for lower-income pregnant women seeking abortions, according to a study published Monday, as the anti-abortion movement ramps up efforts to restrict telehealth access https://t.co/yK7rvV3Mbw ...
American Well (AMWL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
ZACKS· 2025-08-06 01:01
Core Insights - American Well Corporation (AMWL) reported revenue of $70.9 million for the quarter ended June 2025, reflecting a year-over-year increase of 12.9% and surpassing the Zacks Consensus Estimate by 11.42% [1] - The company's EPS was -$1.24, an improvement from -$3.36 in the same quarter last year, with a surprise of 32.61% compared to the consensus estimate of -$1.84 [1] Revenue Breakdown - Platform subscription revenue reached $40.46 million, exceeding the average estimate of $34.05 million by two analysts, marking a year-over-year increase of 47.1% [4] - Other revenue amounted to $7.69 million, surpassing the average estimate of $5.7 million, with a year-over-year change of 17.2% [4] - Revenue from visits was $22.75 million, slightly above the estimated $21.68 million, but represented a decline of 20.8% compared to the previous year [4] Stock Performance - Over the past month, shares of American Well have declined by 13.7%, contrasting with a 1% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]